MetaCap

CapsoVision (CV) vs TransMedics Group (TMDX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CapsoVision (CV) has outperformed TransMedics Group (TMDX) over the past year, gaining 16.8% versus a loss of 34.9%. TransMedics Group is the larger company by market cap ($2.96 billion vs $327.6 million), about 9.0 times the size. TransMedics Group converts more of its revenue into profit, with a net margin of 31.4% versus -186.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CV+16.83%TMDX-34.89%
+187%+62%-64%
Nov 21, 20251 yearNov 20, 2026
CV+38.86%TMDX-34.01%
+213%+75%-64%
Jun 30, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CV versus TMDX key metrics
MetricCVTMDX
Share price$6.11$85.25
Market cap$327.56M$2.96B
1-day change-3.17%-9.33%
YTD return-42.84%-29.92%
1-year return+16.83%-34.89%
5-year return—+289.09%
P/E ratio (TTM)—23.23
Forward P/E—34.31
EPS (TTM)$-0.42$3.67
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.55M$605.49M
Revenue growth (YoY)+15.29%+37.13%
Net income (latest FY)$-25.32M$190.29M
Gross margin52.92%59.92%
Operating margin-188.25%17.93%
Net margin-186.77%31.43%
52-week high$15.37$156.00
52-week low$4.50$60.11
Distance from 52-week high-60.25%-45.35%
Analyst consensusstrong_buybuy
Avg. price target upside+55.48%+23.70%
Average volume173.59K930.13K
Shares outstanding53.61M34.73M
Employees99898
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TransMedics Group is about 9.0 times larger than CapsoVision by market value ($2.96B vs $327.56M).
  • CV has outperformed TMDX by 51.7 percentage points over the past year.
  • TransMedics Group is more profitable, keeping 31.4 cents of every revenue dollar as net income versus -186.8 cents for CapsoVision.
  • TransMedics Group grew revenue faster in its latest fiscal year (+37.13% vs +15.29%).

About CapsoVision

CV stock →

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees

About TransMedics Group

TMDX stock →

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 898 employees

CV vs TMDX FAQ

Which is bigger, CapsoVision or TransMedics Group?

TransMedics Group (TMDX) is larger, with a market capitalization of $2.96B compared with $327.56M for CapsoVision (CV).

Which stock has performed better over the past year, CV or TMDX?

CV returned +16.83% over the past 12 months, compared with -34.89% for TMDX (price return, excluding dividends). Past performance does not predict future results.

Are CapsoVision and TransMedics Group in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons